Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Tesofensine structure and classification Chemical identity: Small molecule drug (not a peptide ) Chemical name: (1R,2S)-2-(3,4-dichlorophenyl)cyclopropyl]methylamine Molecular weight: 216.11 g/mol Synthetic compound (not naturally occurring) Originally code-named NS2330 Why called "tesofensine": Generic pharmaceutical name Developed by NeuroSearch (Danish company) Initially for neurological conditions Repurposed for obesity after accidental discovery Now primarily researched for weight loss Drug classification: Triple monoamine reuptake inhibitor (TRI) Affects: Dopamine, norepinephrine, serotonin Similar mechanism to ADHD medications CNS stimulant properties Schedule classification: Unscheduled but controlled Not a peptide - why included here: Often grouped with weight loss peptides Compared to semaglutide and tirzepatide Sold by peptide vendors Used in weight loss stacks Similar goals as weight loss peptides Learn about what peptides are and how they work at SeekPeptides
In 2021, the FDA approved semaglutide (Wegovy) for chronic weight management in adults who are overweight or obese
Momentum Phase Continuous progress toward goal
Early-life polyphenol intake promotes Akkermansia growth and increase of host goblet cells in association with the potential synergistic effect of Lactobacillus
Trong trng hp khn cp hoc qu liu, gi ngay cho Trung tm cp cu 115 hoc n trm Y t a phng gn nht
This comprehensive consultation will determine your eligibility for GLP-1 medications and create a personalized treatment approach
